Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    TCR2 Therapeutics Inc.

    NASDAQ: TCRR · Real-Time Price · USD
    1.48
    0.00 (0.00%)
    At close: May 31, 2023, 10:00 PM

    TCR2 Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 32.75M 222.56M
    Short-Term Investments
    		 116.43M 43.03M
    Long-Term Investments
    		 n/a n/a
    Other Long-Term Assets
    		 1.94M 1.89M
    Receivables
    		 n/a n/a
    Inventory
    		 n/a n/a
    Other Current Assets
    		 5.16M 10.53M
    Total Current Assets
    		 177.62M 276.13M
    Property-Plant & Equipment
    		 28.68M 45.36M
    Goodwill & Intangibles
    		 n/a n/a
    Total Long-Term Assets
    		 30.61M 47.24M
    Total Assets
    		 208.24M 323.37M
    Account Payables
    		 2.79M 2.14M
    Deferred Revenue
    		 n/a 12.26M
    Short-Term Debt
    		 50.45M 3.37M
    Other Current Liabilities
    		 10.82M 830K
    Total Current Liabilities
    		 64.06M 18.61M
    Long-Term Debt
    		 3.32M 23M
    Other Long-Term Liabilities
    		 n/a 293K
    Total Long-Term Liabilities
    		 3.32M 23.29M
    Total Liabilities
    		 67.38M 41.89M
    Total Debt
    		 53.76M 26.36M
    Common Stock
    		 4K 4K
    Retained Earnings
    		 -501.34M -349.52M
    Comprehensive Income
    		 -445K -13K
    Shareholders Equity
    		 140.86M 281.48M
    Total Investments
    		 116.43M 43.03M

    Add to Watchlist